Contrave: FDA Decision, Chances for Approval

Contrave is a treatment for obesity that consists of bupropion combined with naltrexone. An FDA advisory panel voted 13-7 for its approval in December.  In the end of January, it is going for an official FDA decision. Based on a variety of factors, we would hedge...
Genomic Research Has Limited Impact to Date

Genomic Research Has Limited Impact to Date

In 2000, researchers managed to decode the genome of a human being.  This was heralded as a great breakthrough, and the hope was that genetically based treatments would revolutionize health. 10 years later, very few treatments or changes in medicine have arisen from...

Video Laryngoscopes Market Analysis

This is a competitive market analysis of the video laryngoscope field. McGrath, Glidescope and Storz – these are the names of the three products that mainly control the video laryngoscope market. There are many additional companies and products in video...